Jiangang Duan | Neuroscience | Best Researcher Award

Posted on by ScienceFather

Prof. Jiangang Duan | Neuroscience | Best Researcher Award

Chief Physician at Xuanwu Hospital, Capital Medical University, China

Dr. Jiangang Duan is a distinguished neurologist and researcher at the Department of Emergency and Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China. With over two decades of clinical and academic experience, he specializes in cerebral venous thrombosis (CVT), ischemic stroke, and neuroprotective therapies. His groundbreaking work includes the development of diagnostic imaging techniques, exploration of biomarkers for venous infarcts, and innovative non-drug therapies for ischemic stroke. Dr. Duan is also a dedicated mentor and educator, shaping the next generation of neurologists through his teaching and supervision of postgraduate students. His extensive research has been published in prestigious journals, and he has contributed to the creation of national guidelines for the management of cerebrovascular diseases.

Professional Profile

Education

Dr. Duan holds a Ph.D. and M.D. in Neurology from West China Hospital, Sichuan University (2004–2007), where his dissertation focused on the neuroprotective effects of acupuncture in ischemic stroke models. He earned an M.S. in Human Anatomy and Histoembryology from West China College of Basic and Forensic Medicine (2001–2004), researching ganglioside GM1’s role in neural stem cell differentiation. His academic journey began with a B.S. in Clinical Medicine from Inner Mongolia Medical College (1991–1996), establishing a strong foundation for his future contributions to neuroscience.

Professional Experience

Dr. Duan is an Associate Professor at the Department of Emergency and Neurology, Capital Medical University, Beijing, since 2015. His clinical and research roles involve pioneering treatment strategies for CVT and ischemic strokes. He previously served as a visiting scholar at the Chinese University of Hong Kong (2012–2013), contributing to long-term studies on cardiovascular risks in diabetic patients. Dr. Duan’s work at Xuanwu Hospital includes innovative projects like using DOACs for CVT treatment, evaluating glucocorticoid efficacy, and exploring NF-κB-NLRP3 inflammasome signaling in thrombosis pathogenesis. His efforts have significantly influenced the field of cerebrovascular disease management in China and beyond.

Research Interests

Dr. Duan’s research primarily focuses on the mechanisms and treatments of cerebrovascular disorders, particularly CVT and ischemic strokes. His interests extend to the role of inflammation in thrombosis, novel non-drug therapies for neuroprotection, and the efficacy of anticoagulants like Dabigatran in CVT management. He also investigates biomarkers, such as serum Claudin-5, for predicting venous infarcts and utilizes advanced imaging techniques like MRBTI to evaluate thrombosis stages. His translational research bridges clinical and preclinical studies, aiming to improve diagnostics, treatments, and outcomes for patients with cerebrovascular diseases.

Research Skills

Dr. Duan is proficient in advanced diagnostic imaging methods, including MRBTI, and skilled in conducting both retrospective and prospective studies. He excels in randomized controlled trials, having evaluated the safety and efficacy of anticoagulants and glucocorticoids in cerebrovascular diseases. His expertise in biomarker identification and inflammasome signaling pathways demonstrates his command of molecular and clinical neurology. Additionally, Dr. Duan is adept at statistical analysis, multidisciplinary collaboration, and guideline development, making him a leading figure in cerebrovascular research and clinical practice.

Honors and Awards

Dr. Duan has received numerous accolades, including the prestigious Chinese Medical Science and Technology Award (2019) for his work on non-drug therapies for ischemic stroke. In 2018, he was awarded a fellowship by the European Stroke Research Foundation, where he presented groundbreaking research at the 27th European Stroke Conference in Athens, Greece. He was also recognized with the Outstanding Mentor Management Award in 2021 for his exemplary guidance of postgraduate students. Earlier honors include a scholarship for master’s students at Sichuan University (2002–2003) and recognition for his contributions to cerebrovascular disease management guidelines in China.

Conclusion

Dr. Jiangang Duan is a strong contender for the Best Researcher Award. His robust track record in neurology research, impactful mentorship, and contributions to clinical practice guidelines highlight his expertise and dedication. While there is room to amplify his global impact through high-impact publications and leadership in international projects, his achievements already position him as a distinguished researcher in his field.

Publication Top Notes

  1. Dabigatran etexilate versus warfarin in cerebral venous thrombosis in Chinese patients (CHOICE-CVT): An open-label, randomized controlled trial
    Authors: Ma, H., Gu, Y., Bian, T., Ji, X., Duan, J.
    Journal: International Journal of Stroke
    Year: 2024
    Volume & Pages: 19(6), pp. 635–644
    Citations: 2
  2. Multicenter registry study of cerebral venous thrombosis in China (RETAIN-CH): Rationale and design
    Authors: Bian, H., Wang, X., Liu, L., Wang, L., Ji, X.
    Journal: Brain and Behavior
    Year: 2024
    Volume & Pages: 14(4), e3353
  3. Night shift work was associated with functional outcomes in acute ischemic stroke patients treated with endovascular thrombectomy
    Authors: Yu, W., Ma, J., Guo, W., Zhao, W., Ji, X.
    Journal: Heliyon
    Year: 2024
    Volume & Pages: 10(4), e25916
  4. Predicting Futile Recanalization in Acute Ischemic Stroke Patients Undergoing Endovascular Thrombectomy: The Role of White Blood Cell Count to Mean Platelet Volume Ratio
    Authors: Yu, W., Jia, M., Guo, W., Song, H., Ji, X.
    Journal: Current Neurovascular Research
    Year: 2024
    Volume & Pages: 21(1), pp. 6–14
  5. Severe deep cerebral venous thrombosis associated with ulcerative colitis: one case report | 重 症 脑 深 静 脉 血 栓 形 成 并 溃 疡 性 结 肠 炎 一 例
    Authors: Wang, J.-B., Gu, Y.-Q., Duan, J.-G.
    Journal: Chinese Journal of Contemporary Neurology and Neurosurgery
    Year: 2024
    Volume & Pages: 24(3), pp. 193–198
  6. Tirofiban on Fully Recanalized Stroke with Thrombectomy: A Propensity Score Matching Analysis
    Authors: Guo, W., Li, N., Xu, J., Zhao, W., Ji, X.
    Journal: Journal of Clinical Pharmacy and Therapeutics
    Year: 2024
    Volume & Pages: Article ID: 1171260
  7. Sex differences in cerebral venous sinus thrombosis after adenoviral vaccination against COVID-19
    Authors: Scutelnic, A., van de Munckhof, A., Krzywicka, K., Levi, M., van Gorp, E.C.M.
    Journal: European Stroke Journal
    Year: 2023
    Volume & Pages: 8(4), pp. 1001–1010
    Citations: 1
  8. Cortical vein involvement and its influence in a cohort of adolescents with cerebral venous thrombosis
    Authors: Liu, L., Zhou, C., Jiang, H., Zhou, C., Ji, X.
    Journal: Thrombosis Journal
    Year: 2023
    Volume & Pages: 21(1), Article 78
    Citations: 1
  9. Impaired Dynamic Cerebral Autoregulation in Patients With Cerebral Venous Sinus Thrombosis: Evaluation Using Transcranial Doppler and Silent Reading Stimulation
    Authors: Chen, S., Chen, H., Duan, J., Liu, R., Xing, Y.
    Journal: Ultrasound in Medicine and Biology
    Year: 2023
    Volume & Pages: 49(10), pp. 2221–2226
  10. Cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia in middle-income countries
    Authors: van de Munckhof, A., Borhani-Haghighi, A., Aaron, S., Ferro, J.M., Coutinho, J.M.
    Journal: International Journal of Stroke
    Year: 2023
    Volume & Pages: 18(9), pp. 1112–1120
    Citations: 3

 

Zhongqing Sun | Neuroscience | Best Researcher Award

Posted on by ScienceFather

Dr. Zhongqing Sun | Neuroscience | Best Researcher Award

Assistant Researcher at Xijing Hospital, China

Dr. Zhongqing Sun is an accomplished assistant researcher specializing in neurobiology, with a strong focus on neural regeneration and neuroprotection. His academic journey has led him through prestigious institutions such as The University of Hong Kong and Jinan University, contributing significantly to research on neurological diseases like Alzheimer’s, epilepsy, and stroke. As a leader in translational neuroscience, he integrates basic research with clinical applications, employing innovative techniques to explore potential therapies. Dr. Sun’s work combines cutting-edge molecular biology tools, including RNA-seq, live cell imaging, and stem cell therapies, to investigate new treatments for neurodegenerative diseases. His contributions extend through various high-impact publications and collaborative projects. He continues to drive forward research initiatives with the goal of improving the quality of life for patients with neurological conditions.

Professional Profile

Education:

Dr. Zhongqing Sun holds a Ph.D. in Orthopaedics and Traumatology from The University of Hong Kong, where his research focused on neural regeneration and repair. He completed his Master’s degree in Pharmacology at Jinan University, specializing in the regenerative aspects of the central nervous system, and his Bachelor’s degree in Preventive Medicine from Henan University of Chinese Medicine. This extensive educational background laid a solid foundation for his research in the field of neurology and regenerative medicine, particularly in the context of neurological diseases.

Professional Experience:

Dr. Sun’s professional experience spans multiple prestigious institutions. He is currently an Assistant Researcher at Xijing Hospital, The Fourth Military Medical University, where he leads translational research on common neurological diseases, such as Alzheimer’s disease and stroke. Prior to this, he worked as a research assistant at The University of Hong Kong, focusing on neurodegenerative diseases and eye health, specifically Alzheimer’s and glaucoma. Additionally, he gained valuable experience at The Chinese University of Hong Kong, where he investigated pain mechanisms and the role of microglia in neuropathic pain. He has also contributed to research in electrophysiological recording at the Shanghai Institute of Neuroscience.

Research Interests:

Dr. Sun’s primary research interests lie in the neural regeneration and neuroprotection of the central nervous system. His focus includes developing therapeutic strategies for common neurological conditions, such as Alzheimer’s disease, stroke, and epilepsy. He explores a variety of methodologies, including stem cell therapy, electrical stimulation, neuroinflammatory modulation, and the use of traditional Chinese medicine like Goji berries. His work aims to bridge basic neuroscience with clinical applications, particularly in the development of new treatments for neurodegenerative diseases.

Research Skills:

Dr. Sun is proficient in a wide range of advanced research techniques used to study the central nervous system and neurological diseases. His skills include primary cell culture, cell line maintenance, transgenic animal models, behavioral analysis, electrophysiology, immunostaining, and live cell imaging. He is also experienced in high-throughput molecular techniques such as RNA-seq, single-cell sequencing, Western blotting, and PCR. These technical competencies enable him to conduct in-depth studies on neuroprotection and regeneration, laying the groundwork for novel therapeutic approaches to neurological disorders.

Awards and Honors:

Dr. Zhongqing Sun has been recognized for his outstanding contributions to the field of neuroscience. His work on neural regeneration has earned him numerous accolades, including research grants and awards for innovation. He has received funding from prestigious institutions, such as The University of Hong Kong, and has contributed to several high-profile research projects in the field. His publications in top-tier journals like Biomaterials and Neural Regen Res further attest to his scientific leadership and the impact of his research. Additionally, he serves as a peer reviewer for journals, further validating his expertise and recognition within the scientific community.

Conclusion:

Zhongqing Sun has demonstrated exceptional promise and significant contributions to neuroscience, particularly in neurodegenerative diseases. His interdisciplinary approach to neural regeneration and neuroprotection, combined with his leadership in high-impact research projects, positions him as a strong contender for the Best Researcher Award. To strengthen his profile, expanding the clinical and public outreach of his research could further cement his influence in the field. Given his combination of innovative research, leadership, and academic rigor, he is a deserving candidate for the award.

Publication Top Notes:

  1. Targeting Microglia in Alzheimer’s Disease: Pathogenesis and Potential Therapeutic Strategies
    • Authors: Sun, Z., Zhang, X., So, K.-F., Jiang, W., Chiu, K.
    • Year: 2024
    • Journal: Biomolecules
    • Volume: 14
    • Issue: 7
    • Article Number: 833
    • Citations: 0
  2. Retinal safety and toxicity study of artesunate in vitro and in vivo
    • Authors: Lu, B.-W., Liang, Y.-X., Liu, J.-F., So, K.-F., Chiu, K.
    • Year: 2023
    • Journal: Advances in Ophthalmology Practice and Research
    • Volume: 3
    • Issue: 2
    • Pages: 47–54
    • Citations: 0
  3. Effects of Goji with different origins or different extraction methods on primary mixed glial cells (不同产地或提取工艺枸杞对原代胶质细胞抗氧化及抗炎作用的影响)
    • Authors: Zheng, C., Zhu, R., Sun, Z., So, K.-F., Chiu, K.
    • Year: 2022
    • Journal: Kexue Tongbao/Chinese Science Bulletin
    • Volume: 67
    • Issue: 4-5
    • Pages: 376–384
    • Citations: 2
  4. Lycium barbarum extract promotes M2 polarization and reduces oligomeric amyloid-β-induced inflammatory reactions in microglial cells
    • Authors: Sun, Z.-Q., Liu, J.-F., Luo, W., Hu, Y., Chiu, K.
    • Year: 2022
    • Journal: Neural Regeneration Research
    • Volume: 17
    • Issue: 1
    • Pages: 203–209
    • Citations: 14
  5. Electrical stimulation at nanoscale topography boosts neural stem cell neurogenesis through the enhancement of autophagy signaling
    • Authors: He, L., Sun, Z., Li, J., Zhou, Q., Chiu, K.
    • Year: 2021
    • Journal: Biomaterials
    • Volume: 268
    • Article Number: 120585
    • Citations: 45
  6. Electrical stimulation affects neural stem cell fate and function in vitro
    • Authors: Zhu, R., Sun, Z., Li, C., Chiu, K., He, L.
    • Year: 2019
    • Journal: Experimental Neurology
    • Volume: 319
    • Article Number: 112963
    • Citations: 135

 

ISSAM ABU QEIS | Neuroscience | Best Researcher Award

Posted on by ScienceFather

Dr. ISSAM ABU QEIS | Neuroscience | Best Researcher Award

Neuroscience Researcher of Kunming Medical University, China.

Dr. Issam Abu Qeis is a distinguished medical imaging professional and public health specialist with over 14 years of experience. He holds a Doctoral Degree in Human Anatomy from Kunming Medical University, China, and a Master’s Degree in Public Health from Southern Medical University, Guangzhou. His research focuses on neuroscience, particularly in areas such as neurological defects, brain functions, nerve tissue healing, and neurodegenerative diseases. Dr. Abu Qeis has contributed to several publications in reputable journals, including studies on cell therapy for neurological diseases and the neuroscience of cancer. In addition to his research, he has held leadership roles, including as President of the Alumni Association at Southern Medical University. His comprehensive skill set in medical imaging and public health, coupled with his commitment to improving healthcare quality, makes him a significant contributor to the medical field. Dr. Abu Qeis is currently a researcher at the Institute of Neuroscience, Kunming Medical University.

Profile
Education

Dr. Issam Abu Qeis has a robust educational background that underpins his expertise in medical imaging and neuroscience. He is currently pursuing a Doctoral Degree in Human Anatomy at Kunming Medical University in China, where his research focuses on advanced topics in neuroscience, including neurological defects and brain functions. Prior to this, Dr. Abu Qeis earned a Master’s Degree in Public Health from Southern Medical University in Guangzhou, China, in 2017, equipping him with a comprehensive understanding of public health issues and their impact on medical practices. His academic journey began with a Bachelor’s Degree in Medical Imaging Sciences from Arab American University in Jenin, Palestine, which he completed in 2012. This foundational education in medical imaging provided him with the technical skills and knowledge necessary for his subsequent roles in radiology and medical research, paving the way for his contributions to the fields of neuroscience and public health.

Professional Experience

Dr. Issam Abu Qeis is an accomplished medical imaging professional and neuroscience researcher with over 14 years of diverse experience in national and international settings. Currently, he serves as a Researcher at the Institute of Neuroscience, Kunming Medical University, China, where he focuses on neurological defects, brain functions, and nerve tissue healing. His extensive background includes roles as a Radiographer and Head of the Radiology Department at Shunnara Medical Center in Ramallah, Palestine, where he led radiological services and ensured high-quality imaging standards. Previously, he worked as a Medical Imaging Professional with the Ministry of Health in Palestine and at various medical centers, gaining expertise in advanced imaging technologies and public health practices. Dr. Abu Qeis is also the President of the Alumni Association for the Public Health Branch at Southern Medical University, China, highlighting his leadership and commitment to enhancing public health and medical education.

Research Interest

Dr. Issam Abu Qeis is deeply engaged in research within the fields of neuroscience and medical imaging, with a particular focus on understanding and addressing neurological defects and degenerative diseases. His work explores the intricate functions of the brain, the healing of nerve tissues, and the treatment of neurological disorders, including gliomas and other neurodegenerative conditions. Dr. Abu Qeis is also invested in the application of neuroradiology and radiology techniques to improve diagnostic accuracy and patient outcomes. His research extends to the role of cell therapy in treating neurological diseases, offering promising insights into innovative therapeutic approaches. Additionally, Dr. Abu Qeis is interested in public health, particularly in quality assurance systems within radiology centers. His multidisciplinary approach, combining neuroscience, imaging, and public health, reflects a commitment to advancing medical science and improving the quality of healthcare delivery.

Research Skills

Dr. Issam Abu Qeis possesses a comprehensive skill set in medical imaging and neuroscience research, underpinned by over 14 years of experience. His expertise spans advanced medical imaging techniques, including X-ray, CT, MRI, and ultrasound, with a particular focus on radiographic contrast studies. Dr. Abu Qeis is proficient in the analysis and interpretation of neuroimaging data, which he applies to research in neurological defects, brain functions, and degenerative diseases. His research acumen is further demonstrated by his ability to design and execute complex studies, particularly in the realms of glioma research and nerve tissue healing. He is skilled in using statistical software like SPSS for data analysis and has a strong command of research methodologies, from hypothesis formulation to publication. Dr. Abu Qeis’s ability to integrate interdisciplinary knowledge from public health and neuroscience enhances his research impact, making significant contributions to both fields.

Awards and Recognition

Dr. Issam Abu Qeis has earned significant recognition throughout his career in neuroscience and medical imaging. His work on neurological diseases, particularly in the areas of nerve tissue healing and glioma research, has been widely acknowledged. Dr. Abu Qeis has been honored with membership certifications from prestigious organizations, including the European Society of Radiology and the Palestinian Society of Radiology, reflecting his contributions to advancing medical imaging practices. He has also been recognized for his leadership as the President of the Alumni Association for the Public Health Branch at Southern Medical University, where he has played a crucial role in fostering international collaboration. Additionally, his research has been published in reputable journals, including Ibrain, further solidifying his reputation in the scientific community. Dr. Abu Qeis’s dedication to public health and neuroscience research continues to earn him accolades and respect within the global medical and research communities.

Conclusion

Issam Abu Qeis is a well-qualified candidate for the Best Researcher Award, particularly in the field of neuroscience and medical imaging. His extensive experience, leadership roles, and dedication to research make him a strong contender. However, focusing on enhancing the impact and visibility of his research, as well as securing funding and expanding his teaching and mentorship roles, could further strengthen his candidacy and increase his chances of winning the award.

Publications Top Notes

  1. Neuroscience of Cancer: Research Progress and Emerging of the Field
    • Authors: Issam AbuQeis, Yu Zou, Ying‐Chun Ba, Abeer A. Teeti
    • Year: 2024-08-14
    • DOI: 10.1002/ibra.12172
  2. Role and Limitation of Cell Therapy in Treating Neurological Diseases
    • Authors: Yu‐Qi Li, Peng‐Fei Li, Qian Tao, Issam J. A. Abuqeis, Yan‐Bin Xiyang
    • Year: 2024-03
    • DOI: 10.1002/ibra.12152